作者: Glen T. Schumock , A. Simon Pickard
DOI: 10.2146/AJHP090150
关键词:
摘要: Purpose. An overview of the emerging field comparative effectiveness research (CER) and its relevance to pharmacists pharmacy-based decision-makers is provided. Summary. The U.S. government investing over $1 billion on CER next two years. This investment in part driven by recognition that, despite having highest per capita health care expenditures world, United States does not always perform well measures compared with other countries. There also increased awareness limited information provided results traditional randomized clinical trials inform decisions about therapeutic alternatives as applied actual practice. Comparative studies have important principal components: (1) comparison or more agents interventions that are considered true (2) examination effects (outcomes) differ from efficacy several ways, including question addressed, groups, patient population, setting, outcomes measured, validity. Studies within scope can be categorized primary secondary studies. used compare medical devices, procedures, services, any competing intervention. Conclusion. an area relevant many areas care, especially pharmacotherapy. knowledge gained when applying drug making related therapy.